Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension

ClinicalTrials.gov ID: NCT00380068

Public ClinicalTrials.gov record NCT00380068. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 8:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ARIES-3: A Phase 3, Long-Term, Open-Label, Multicenter Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension

Study identification

NCT ID
NCT00380068
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
224 participants

Conditions and interventions

Interventions

  • Ambrisentan Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2006
Primary completion
Jun 30, 2008
Completion
Apr 30, 2009
Last update posted
Apr 4, 2012

2006 – 2009

United States locations

U.S. sites
34
U.S. states
23
U.S. cities
29
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
Arizona Pulmonary Specialists, Ltd Phoenix Arizona 85013
UCSD Medical Center, Thornton Hospital La Jolla California 92037
Greater Los Angeles, VA Medical Center Los Angeles California 90073
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Torrance California 90502
University of Colorado Health Sciences Center Aurora Colorado 80045
University of Connecticut Health Center Farmington Connecticut 06030
Pulmonary Hypertension Clinic Mount Sinai Medical Center Miami Beach Florida 33140
Suncoast Lung Center Sarasota Florida 34233
Medical College of Georgia Augusta Georgia 30912
Atlanta Institute for Medical Research, Inc. Decatur Georgia 30030
University of Chicago Hospitals Chicago Illinois 60637
University of Iowa Hospitals and Clinics Iowa City Iowa 52242
Johns Hopkins University Baltimore Maryland 21287
Tufts-New England Medical Center Boston Massachusetts 02111
Massachusetts General Hospital Boston Massachusetts 02114
Boston Adult Congenital Heart Service Boston Massachusetts 02115
Boston University School of Medicine Boston Massachusetts 02118
Mayo Clinic Rochester Minnesota 55905
Washington University School of Medicine St Louis Missouri 63110
University of Medicine & Dentistry of New Jersey Newark New Jersey 07103
Newark Beth Israel Medical Center Newark New Jersey 07112
New York Presbyterian Pulmonary Hypertension Center New York New York 10032
Mary Parkes Asthma Center Rochester New York 14623
Duke University Medical Center Durham North Carolina 27710
The Lindner Clinical Trial Center Cincinnati Ohio 45219
University Hospitals of Cleveland Cleveland Ohio 44106
Legacy Clinical Northwest Portland Oregon 97210
Allegheny General Hospital Pittsburgh Pennsylvania 15212
University of Pittsburgh Medical Center Presbyterian Pittsburgh Pennsylvania 15213
Rhode Island Hospital Providence Rhode Island 02903
Lexington Pulmonary and Critical Care Lexington South Carolina 29072
Baylor College of Medicine Houston Texas 77030
University of Virginia Health Sciences Center Charlottesville Virginia 22908

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00380068, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 4, 2012 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00380068 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →